E. J. M. Mattijssen

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist et al. · Blood · 2016 · 112 citations · Full text

Medicine, Hematology, Oncology +14

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

Kim Holtzer-Goor, Martyn Ronald Schaafsma, Peter Joosten et al. · Quality of Life Research · 2015 · 54 citations · Full text

Medicine, Hematology, Oncology +16

Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry

Leonie Strobbe, Saskia A. M. van der Schans, Sanneke Heijker et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 13 citations

Medicine, Hematology, Pathology +14

Real-world costs of chronic lymphocytic leukaemia in the Netherlands

Kim Holtzer-Goor, Clazien Bouwmans-Frijters, M. Ronald Schaafsma et al. · Leukemia Research · 2013 · 10 citations

Pharmacy, Oncology, Pharmacoeconomics +14